Development or regulatory milestones incurred
Mirum Pharmaceuticals, Inc.·Products & Services·2 segments
Breakdown
Segments
LivmarliView metric
VolixibatView metric
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Livmarli | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Volixibat is derived from annual filings.